MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-7.88 Cr | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-7.88 Cr |
| Mar2025 | ₹3.66 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹14 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-7.88 Cr | Negative | |
| Mar2025 | ₹3.66 Cr | -65.52 | |
| Mar2024 | ₹11 Cr | -30.98 | |
| Mar2023 | ₹15 Cr | 11.78 | |
| Mar2022 | ₹14 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,932.9 Cr | 1.7% | 27.4% | 81.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.7% |
27.4% |
81.2% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses